Sotera Health Company - Common Stock (SHC)

Let’s dig into the relative performance of Bio-Techne (NASDAQ:TECH) and its peers as we unravel the now-completed Q4 research tools & consumables earnings season.

Looking back on research tools & consumables stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Sotera Health Company (NASDAQ:SHC) and its peers.

SHC earnings call for the period ending December 31, 2024.

Healthcare services company Sotera Health (NASDAQ:) met Wall Street’s revenue expectations in Q4 CY2024, but sales fell by 6.5% year on year to $290.2 million. Its non-GAAP profit of $0.21 per share was in line with analysts’ consensus estimates.

On Tuesday, Sotera Health stock hit a key technical milestone, with its Relative Strength Rating climbing to 91, up from 86 the day before.

Healthcare services company Sotera Health (NASDAQ:) will be reporting results tomorrow before market hours. Here’s what to look for.

SHC earnings call for the period ending September 30, 2024.

Sotera Health shares are trading higher by 5.5% during Thursday's session. The company late Wednesday announced a secondary offering of 25 million shares.

SHC earnings call for the period ending June 30, 2024.

SHC earnings call for the period ending March 31, 2024.

SHC stock results show that Sotera Health beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it concluded its strategic evaluation process, announced management succession and board changes. Lifecore Biomedical shares dipped 31.7% to $4.91 on Wednesday.

SHC earnings call for the period ending December 31, 2023.